The Research Foundation For The State University Of New York

The Research Foundation For The State University Of New York, operating as SUNY at Binghamton, is a tax-exempt nonprofit research administrator that serves as the fiscal and administrative agent for federal research contracts and grants across the State University of New York system. The organization competes without set-aside eligibility and acts predominantly as a prime recipient and prime contractor for federally-funded university research.

SUNY at Binghamton's federal research portfolio spans fundamental science and applied engineering across the physical sciences, biomedical research, and education. Recent work exemplifies the breadth: a $2.456 million FDA contract for estimation of in-vivo tissue properties using clinical MR thermometry (awarded September 2026); a $900 thousand NIST purchase order to develop an advanced test vehicle for studying semiconductor materials reliability (December 2025); and a $6.25 million Department of Energy cooperative agreement to develop and demonstrate grid-scale energy storage using polymer electrolyte and ceramic battery technology (February 2026). On the grant side, the organization serves as prime recipient for a $1.379 million National Institute on Drug Abuse award for model-informed drug development and precision dosing of opioid medications in lactating mothers (August 2026), a $730 thousand National Science Foundation grant for a summer enrichment program using geoarchaeology to engage high school students in STEM (March 2027), and a $805 thousand NSF award for acquisition of an atomic layer deposition system for research and training in microelectronics (April 2026).

Customer concentration is heavily skewed toward federal research agencies rather than a distributed customer base. The National Science Foundation dominates by count—257 awards, approximately 28 percent of all awards in the portfolio—followed by the National Institutes of Health (52 awards). The Department of Education Office of Postsecondary Education, NSF's Division of Civil, Mechanical, and Manufacturing Innovation, and the National Institute on Alcohol Abuse and Alcoholism complete the top tier. These top five funding sources account for roughly 43 percent of all awards. By potential value, NIST leads on a per-dollar basis ($979 thousand across 13 awards), though NSF and NIH remain large in absolute terms. The organization works with 108 distinct federal customer agencies overall, indicating significant diversification and reach across the federal research landscape.

Activity has grown substantially, from 70 awards in 2023 to 81 in 2024, then moderated to 59 in 2025 and 34 in 2026; the 2027 count (4 awards) reflects the recency of the data snapshot. Seventy-four awards carry ultimate completion dates within the next twenty-four months and total $2 million in combined potential value, creating material recompete exposure. The organization's obligation rate exceeds potential value (713 percent across all awards), indicating that many awards have been amended upward or that obligated amounts reflect multi-year commitments executed under initial lower-value authorizations.

In its subcontractor role, SUNY at Binghamton performs specialized research for major primes including Mayo Clinic, Purdue University, Jackson Laboratory, Cornell University, and The Johns Hopkins University. Subtopic work includes electrochemical oxygen generation for cell transplantation devices under a Mayo Clinic cooperative agreement, behavioral phenotyping and genetics research conducted through Jackson Laboratory, and data management and outcomes evaluation on NSF innovation and NOAA resilience projects.

The organization's corporate structure reflects its role as a child entity of the parent Research Foundation For The State University Of New York (Albany headquarters), which serves as the system-wide fiscal conduit. This structure enables SUNY at Binghamton to access large federal research opportunities while maintaining administrative and financial accountability through the system entity. Performance locations are primarily Binghamton, New York, with some work performed at partner institutions (e.g., Pennsylvania State University for poultry vaccine efficacy testing).

The portfolio emphasizes early-stage and fundamental research with a strong STEM education and workforce development component. Projects routinely integrate student training, K-12 outreach, and curriculum development alongside core research delivery. Set-aside competition is absent; the organization pursues full-and-open federal research opportunities across agencies, with no characteristic reliance on HUBZone, 8(a), SDVOSB, or WOSB designations.